The HIV-1 Rev binding family of proteins: The dog proteins as a study model

Endocrine, Metabolic and Immune Disorders - Drug Targets

Volumn 8, Issue 1, 2008, Pages 30-46

  Panaro, Maria A ^a   Mitolo, Vincenzo ^a   Cianciulli, Antonia ^a   Cavallo, Pasqua ^a   Mitolo, Carlo I ^a   Acquafredda, Angela ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Dog; Evolution; HIV 1; HRB; Man; Rev; RIP; Unspliced RNA export

Indexed keywords

ASPARAGINE; BINDING PROTEIN; GLYCINE; HIV 1 REV BINDING PROTEIN; MESSENGER RNA; PHENYLALANINE; PROLINE; REV PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CELL NUCLEUS; CELL VIABILITY; COMPLEX FORMATION; CYTOPLASM; DOG; DROSOPHILA; DRUG TARGETING; FRAMESHIFT MUTATION; GENE DELETION; GENE INSERTION; GENETIC CONSERVATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HYPOTHESIS; INTRON; NONHUMAN; NUCLEAR PORE; NUCLEOTIDE SEQUENCE; PROTEIN FAMILY; PROTEIN FUNCTION; RNA TRANSLATION; VIRION; VIRUS REPLICATION; ZINC FINGER MOTIF; ANIMAL; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; PROTEIN BINDING; REVIEW; VIROLOGY;

AMINO ACID SEQUENCE; ANIMALS; DOGS; HIV INFECTIONS; HIV-1; HUMANS; PROTEIN BINDING; REV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

EID: 45549110343     PISSN: 18715303     EISSN: None     Source Type: Journal    
DOI: 10.2174/187153008783928325     Document Type: Article

References (26)

1. Coffin, J.M.; Hughes, S.H. and Varmus, H.E. (Eds) (1997) Retroviruses, Cold Spring Harbor Laboratory Press, Plainview (NY).
2. Alberts, B.; Johnson, A.; Lewis, J.; Raff, M.; Roberts, K. and Walter, P. (2002) Molecular Biology of the Cell (4th edition), Garland, New York (NY).
3. Levy, J.A. (2007) HIV and the Pathogenesis of AIDS (3rd edition), ASM Press, Washington, DC.
4. Thumb, W.; Graf, C.; Parslow, T.; Schneider, R. and Auer, M. (1999) Spectrochim. Acta. A. Mol. Biomol. Spectrosc., 55A(13), 2729-2743.
5. Yu, Z.; Sánchez-Velar, N.; Catrina, I.E.; Kittler, E.L.W.; Udofia, E.B. and Zapp, M.L. (2005) Proc. Natl. Acad. Sci. USA, 102(11), 4027-4032.
6. Stutz, F.; Izaurralde, E.; Mattaj, I.W. and Rosbash, M. (1996) Mol. Cell Biol., 16(12), 7144-7150.
7. de Beer, T.; Carter, R.E.; Lobel-Rice, K.E.; Sorkin, A. and Overduin, M. (1998) Science, 281(5381), 1357-1360.
8. Doria, M.; Salcini, A.E.; Colombo, E.; Parslow, T.G.; Pelicci, P.G. and Di Fiore, P.P. (1999) J. Cell Biol., 147 (7), 1379-1384.
9. Kang-Decker, N.; Mantchev, G.T.; Juneja, S.C.; McNiven, M.A. and van Deursen, J.M. (2001) Science, 294(5546), 1531-1533.
10. Randazzo, P.A. and Hirsch, D.S. (2004) Cell Signal, 16(4), 401-413.
11. Nie, Z. and Randazzo, P.A. (2006) J. Cell Sci., 119(Pt 7), 1203-1211.
12. Corpet, F. (1988) Nucl. Acids Res., 16(22), 10881-10890.
13. Kyte, J. and Doolittle, R.F. (1982) J. Mol. Biol., 157(1), 105-132.
14. Prossnitz, E.R. and Ye, R.D. (1997) Pharmacol. Ther., 74(1), 73-102.
15. Kräusslich, H.-G. and Müller, B. (2003) in Encyclopedic Reference of Molecular Pharmacology, (Offermanns, S. and Rosenthal, W., Eds), Springer, Berlin, Heidelberg, New York, Hong Kong, London, Milan, Paris, Tokyo, pp. 133-139.
16. Reeves, J.D. and Piefer, A.J. (2005) Drugs, 65(13), 1747-1766.
17. Meadows, D.C. and Gervay-Hague, J. (2006) Chem. Med.Chem., 1(1), 16-29.
18. Baba, M. (2006) Antiviral Res., 71(2-3), 301-306.
19. Oberg, B. (2006) Antiviral Res., 71(2-3), 90-95.
20. Salama, N.N.; Endsley, A. and Ho, R.J. (2006) Infect. Disord. Drug Targets, 6(2), 107-119.
21. Klumpp, K. and Mirzadegan, T. (2006) Curr. Pharm. Des., 12(15), 1909-1922.
22. Chakraborty, C. (2007) Curr. Drug Targets, 8(3), 469-482.
23. Ptak, R.G. (2002) Expert Opin. Investig. Drugs, 11(8), 1099-1115.
24. Baba, M. (2004) Curr. Top. Med. Chem., 4(9), 871-882.
25. Cochrane, A. (2004) Curr. Drug Targets Immune Endocr. Metabol. Disord., 4(4), 287-295.
26. Modem, S., Reddy, T.R. (2008) J. Cell Physiol., 214(1), 14-19.